HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients

Article information

Korean J Intern Med. 1988;3(1):15-23
Department of Internal Medicine, College of Medicine, Seoul, National University, Seoul, Korea
Department of Surgery
Department of Microbiology
Department of Pathology
Seoul District Armed Forces General Hospital
Address reprint requests. Bo Youn Cho, M.D., Department of Internal Medicine, College of Medicine, Seoul National University #28, Yun Kun Dong, Chongno Ku, Seoul, 110-744, Korea

Abstract

To confirm the expression of HLA-DR antigen on the thyrocytes of Graves’ disease patients and study the relation between the degree of DR antigen expression and clinical or laboratory indices, double immunofluorescence and immunoenzymatic staining were performed on frozen thyroid sections. DR antigen was expressed on the thyrocytes of 8 of 11 patients with Graves’ disease (73%) but not found on the thyrocytes from 6 normal controls. The degree of DR antigen expression had no apparent correlation with the age, duration of the disease, activity of TBII, titers of antimicrosomal and antithyroglobulin antibody. There was no apparent spatial or quantitative relation between lymphoid follicle formation and the DR antigen expression on the thyroid follicles. But DR antigen tended to be expressed on the thyroid tissue with interstitial, lymphocyte infiltration. In conclusion, DR antigen was expressed on the thyrocytes of Graves’ disease patients but the clinical and immunological significance remains to be clarified.

INTRODUCTION

Graves’ disease has been regarded as an organ-specific autoimmune disease due to the autoantibodies directed to the receptors of Thyroid Stimulating Hormone (TSH) or their adjacent antigenic domains.14) However, the immunological mechanisms leading to the development of these autoantibodies are still elusive, albeit many theories presented so far.513)

Recently, it was reported that the HLA-DR antigen was expressed on the thyrocytes of the patients with Graves’ disease and Hashimoto’s disease.14, 15) Moreover, the DR antigen was reportedly able to be induced on the normal thyrocytes by lectins.16) These findings suggest that the thytrocytes might become antigen-presenting cells in an appropriate condition to induce or amplify the autoimmune processes,17) considering that the DR antigen is necessary for antigen presentation.1820) DR antigen was also found to be expressed on the islet cells of the patients with type I diabetes mellitues21) and the bile duct cells of the patients with primary biliary cirrhosis,22) suggesting the possible role of the aberrant DR antigen expression in the broad gamut of autoimmune diseases. However, the immunological impact of these phenomena is not clarified and it is still controversial whether lymphocyte infiltration in the thyroid gland is related to the DR antigen expression on the thyrocytes or not.

We conducted this investigation to document the HLA-DR antigen expression on the thyrocytes of Graves’ disease patients and to study the relationship between the degree of DR antigen expression, & clinical or laboratory indices, and the degree of lymphocyte infiltration in the thyroid gland.

MATERIALS AND METHODS

1. Materials

Specimens from the Graves’ disease patients were obtained during thyroidectomy from 11 patients who were in euthyroidism with the antithyroid drug and those of normal controls, from the adjacent normal portion of 6 patients with nodular goiter. The specimens were immediately frozen below −20°C and thawed within 1 month of storage to be cut into 6 μm sections for double indirect immunofluorescence staining.

Monoclonal antibody to human HLA-DR antigen was produced at the Department of Microbiology, College of Medicine, Seoul National University23) (1BD9-2). Sera containing antimicrosomal antibody were obtained from 2 patients with Graves’ disease whose titer of antimicrosomal antibody was over 1:12802 without detectable antithyroglobulin antibody. FITC-labeled or unlabeled rabbit antimurine IgG (heavy & light chain specific), and rhodamine-labeled rabbit antihuman IgG (heavy & light chain specific) were purchased from Cappel (Malvern, PA, USA). Monoclonal anti-CD5, CD4, CD8 antibodies (T1, T4, T8 antibody, respectively) and AP-AAP complex were purchased from DAKO Corp. (Santa Barbara, CA, USA). Bovine serum albumin, Fast Red TR Salt (5-chloro-2-toluidinediazonium chloride hemizine chloride), levamisole and Naphthol AS-MX sodium salt (3-hydroxy-2-Naphthoic acid 2,4-dimethylanilide) were purchased from Sigma (St. Louise, MO, USA).

METHODS

1. Immunofluorescence Staining

The appropriate cut sections of frozen tissue were incubated for 30 min in a humid chamber at 37°C with the culture supernatant of the 1BD9-2 cell line and a 1:100 dilution of the sera containing antimicrosomal antibody. Then the sections were washed 3 times with phosphate buffered saline for a total of 30 min, and were reincubated with a 1:20 dilution of FITC-labeled rabbit antimurine IgG and rhodamine-labelled rabbit antihuman IgG in a phosphate buffered saline containing 0.1 % bovine serum albumin for 30 min in a humid chamber at 37°C. The sections were washed 3 times with phosphate buffered saline again for a total of 30 min, and examined under a fluorescent microscope (American Optical) after mounting with glycerol in phosphate buffered saline. The negative control slide was made by incubating the adjacent cut sections with the second antibodies only. Autofluorescence was excluded by scrutinizing unstained cut sections under the fluorescent microscope, and the cross-immunoreactivities between human IgG & antimurine IgG, or murine IgG & antihuman IgG were tested by cross-staining of the cut sections to yield negative results. The number of prominently bright-green follicles compared to the negative control slide was counted in over 50 thyroid follicles and the ratio was rounded to one decimal.

2. Alkaline Phosphatase-Antialkaline Phosphatase Staining

The specimen of one patient which showed large clusters of DR antigen positive cells in the vicinity of the thyroid follicles with double immunofluorescence staining was subjected to AP-AAP (Alkaline Phosphatase-Antialkaline Phosphatase) double bridge staining24,25) using T1, T4 or T8 monoclonal antibody as the first antibody. The cut frozen sections were incubated with a 1:40 dilution of the first antibody in phosphate buffered saline for 30 min at room temperature and washed with phosphate buffered saline 3 times for a total of 6 min subsequently. Then they were incubated with a 1:50 dilution of antimurine IgG for 30 min at room temperature and washed again 3 times with phosphate buffered saline for a total of 6 min followed by incubation with 1:50 dilution of AP-AAP complex and rewashing. The incubation with the second antibody and the AP-AAP complex were recapitulated to make a “double bridge” and the processed sections were incubated with a color substrate solution made by dissolving 10 mg of Fast Red TR Salt, 2.4 mg of levamisole and 2 mg of Naphthol AS-MX sodium salt in 0.1 M Tris buffer (pH 8.2), 10 ml. The final sections were counterstained with hematoxylin.

3. Measurement of the Autoantibodies & TSH Receptor Antibody

The titers of antimicrosomal antibody and antithyroglobulin antibody were measured with the hemagglutination method using the kits produced by Fujirebio (Japan). The activity of TBII (TSH Binding Inhibitory Immunoglobulin) was measured using the kits produced by R.S.R. Limited (Cardiff, Wales, UK).

4. Scrutiny of Lymphocyte Infiltration

Ten fields of hematoxylin-eosin stained sections were examined in low-power microscopy to grade the degree of lymphoid follicle formation from − to + + + +. The presence of interstitial lymphocyte infiltration was searched apart from lymphoid follicle formation.

5. Statistical Analysis

Kendall’s W test of concordance was employed to study the correlation between the degree of DR antigen expression on the thyrocytes, and clinical or laboratory indices, the degree of lymphocyte infiltration in the thyroid gland.

RESULTS

1. DR Antigen Expression on the Thyroid Tissue

All of the thyroid follicles of both the normal controls and the patients with Graves’ disease were stained with rhodamine suggesting the presence of microsomal antigen on the thyrocytes (Fig. 1).

Fig. 1.

Closed arrow indicates positive rhodamine staining on the thyroid follicles of Graves’ disease patient. A large patch of cells adjacent to the thyroid follicles shows negative rhodamine staining (long arrow), but the central area of the patch shows positive rhodamine staining (open arrow).

DR antigen was not found at all on the frozen sections of the normal thyroid tissues from 6 subjects. Strong or weak autofluorescence that could be discerned from true staining by the yellow color instead of green, was observed occasionally along the inner side of large or small vasculatures (Fig. 2).

Fig. 2.

The thyroid follicles of the normal control were DR-antigen negative (closed arrow). The yellow line along the inner side of an arteriole represents autofluorescence (open arrow) (See text.)

Of 11 patients with Graves’ disease, 8 patients (73%) showed DR antigen expression on their thyroid follicles, and the ratio of DR antigen-positive follicles varied between 10–80% (Fig. 3, Table 1). The staining pattern was patch, i.e. DR-positive thyrocytes were rather aggregated. There was no apparent correlation between the degree of HLA-DR antigen expression on the thyroid follicles and the clinical or laboratory indices including age, duration of the disease, the activity of TBII, and the titers of antimicrosomal antibody & antithyroglobulin antibody (p>0.1 in all tests).

Fig. 3.

The thyrocytes of Graves’ disease patients were DR antigen-positive (short arrow), as is the large patch of cells adjacent to the thyroid follicles (long arrow).

HLA-DR Expression on the Thyroid Follicles of Graves’ Disease Patients in Relation to the Laboratory Indices and Lymphocyte Infiltration

2. Nature of Infiltrating Cells around Thyroid Follicles

On the several frozen sections from the patients with Graves’ disease, large or small clusters of microsomal antigen-negative, DR antigen-positive cells were observed after double immunofluorescence staining (Fig. 1, 3). The cells in those clusters were positively stained with the T1 antibody except in the central area (Fig. 4). The lymphocytes stained with T1 antibody also stained with T4 antibody or T8 antibody in the staining of the adjacent sections of the tissue (Fig. 5, 6). There was no apparent discrepancy in the distribution patterns of T4-positive helper/inducer T-lymphocytes and T8 positive suppressor/cytotoxic T-lymphocytes but the quantitative ratio was about 3:1. The lymphocytes of both subsets were also scattered in the thyroid follicles (Fig. 7). Meanwhile, the cells in the central area of those DR antigen-positive clusters showed positive rhodamine staining not only in case of the regular double immunofluorescence staining but also in the control staining, i.e. in the absence of the antimicrosomal antibody, suggesting the presence of a surface immunoglobulin on the cells in the central area (Fig. 1, 3). So the cells in the central area of those clusters were thought of as B lymphocytes considering that they had a surface immunoglobulin in addition to the DR antigen and were not stained with T1 antibody (Fig. 4). Germinal centers were also observed occasionally in the central area of those DR-positive clusters with light microscopy.

Fig. 4.

The cells in the large patch were T1 antigen-positive except the central area.

Fig. 5.

Majority of the T1-positive cells were T4 antigen-positive.

Fig. 6.

Minority of the T1-positive cells were T8 antigen-positive.

Fig. 7.

Lymphocytes were also scattered in the thyroid follicles.

There was no apparent spatial or quantitative relation between the lymphoid follicle formed and the DR antigen expression on the thyroid follicles (p>0.1). But the degree of lymphoid follicle formation and the presence of interstitial lymphocyte infiltration did not coincide, and all 4 cases with interstitial lymphocyte infiltration showed DR antigen expression on 50% or above of their thyroid follicles examined (Table 1).

DISCUSSION

The negative DR antigen staining of the normal thyroid follicle is consistent with the previous reports of other investigators and the classical theory that the class II antigens are localized on the surface of immune cells including B lymphocytes, activated T-lymphocytes and various bone marrow-derived antigen presenting cells such as the macrophage or dendritic celll.18,19,26,27) Meanwhile, there are occasional reports that HLA-DR antigen was found on the endothelial cells of normal kidney glomeruli,28) and Hanafusa et al. reported the presence of a few DR antigen positive endothelial cells on the sections of normal thyroid tissue. We observed linear or caret-like fluorescence along the inner side of large or small vessels, respectively, but the color was rather yellow and fluorescence was also found on the unstained frozen sections indicating that it was due to autofluorescence. The autofluorescence along the inner side of the vasculatures may be accounted for by the presence of elastic fiber or type IV collagen.29)

The observation that DR antigen was found on the thyroid follicles of patients with Graves’ disease is compatible with the results of other investigators.14,15) The presence of 3 patients whose frozen sections gave negative results with DR staining and the variable degree of DR antigen expression in the positive cases suggest the possibility that DR antigen expression may not be a crucial event in the pathogenesis of Graves’ disease or DR antigen may be expressed on the thyrocytes only in a certain period of the disease. It is also probable that the degree of DR antigen expression may be related to the HLA type of patients considering the reports that the incidence of Graves’ disease is related to the HLA type.12,13) But it must to borne in mind in the interpretation of these results that the cut section represents only a certain 2-dimensional space of the whole thyroid gland.

The finding that the degree of DR antigen expression on the thyroid follicles has no relation with the clinical and laboratory indices can also be explained in the same manner as the variable degree of DR antigen expression itself.

The immunological significance of aberrant DR antigen expression on the epithelial cells such as thyrocytes is far from clear, although it was elucidated that induction of DR antigen expression on the cultured normal thyrocytes is, at least partly, due to gamma-interferon secreted by T-lymphocytes.30,31) The epithelial cells which have surface DR antigen from any cause might present their other normal or abnormal surface antigens to the helper/inducer T-lymphocytes simulating antigen presenting cells if other conditions for the antigen presentation are permissive,16,17) considering that the DR antigen on the antigen presenting cells is co-presented to the autologous helper/inducer T-lymphocytes with foreign antigens.20) But it may merely be an epiphenomenon without specific consequence reflecting a response to various nonspecific or nonimmunological stimuli, or have a protective effect against those stimuli.32) Recently, it has been reported that the thyrocytes and endothelial cells with aberrant DR antigens on their surface could present autologous or heterologous antigens to the helper T-lymphocytes.33,34) But there seems to be no direct evidence that DR antigen expression on the epithelial cells plays a role in the induction or amplification of the autoimmune processes.

The clusters of DR antigen-positive, microsomal antigen-negative cells seemed to be lymphocytes judging from the light microscopic findings, which was confirmed later in one case by immunoenzymatic staining. The positive rhodamine staining on the cells in the central area of the large clusters was an unexpected event, but the same positive staining in the control slides gave an answer to this question. The quantitative T4/T8 ratio in that case was similar to the results of other studies concerning lymphocyte infiltration in Graves’ disease.15) DR antigen-positivity of the infiltrating T-lymphocytes suggest that they were “activated.” 35,36) The infiltrating T-lymphocytes might be a probable candidate for a source of gamma-interferon which can induce the thyrocytes to express DR antigen. The present finding that all 4 cases with diffuse interstitial lymphocyte infiltration expressed DR antigen on over 50%, of their thyroid follicles supports the suggestion that infiltrating lymphocytes might be responsible for DR antigen expression on the thyroid follicles. But in contrast to the interstitial lymphocyte, the lymphoid follicles formed in the thyroid tissue did not seem to be directly related with the DR antigen expression on the thyrocytes.

Acknowledgements

The authors are indebted to Wang Jae Lee, M.D. and Prof. Ka Yong Jang, Dept. of Anatomy, College of Medicine, Seoul National University for their technical & material aid in performing AP-AAP staining.

References

1. Docter R, Bos G, Visser TJ, Hennemann G. Thyrotropin binding inhibiting immunoglobulins in Graves’ disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clin Endocrinol 12:143. 1980;
2. Hinds WE, Takas N, Rapoport B, Filette S, Clark OH. Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab 51:1204. 1981;
3. Cho BY, Koh CS, Lee M. The clinical significance of TSH binding inhibiting immunoglobulin in autoimmune thyroid diseases. Korean J Intern Med 28:299. 1985;
4. Koh CS. The roles of the TSH receptor antibodies in autoimmune thyroid diseases. Korean J Nucl Med 20:85. 1986;
5. Roitt IM, Torrigiani G. Identification and estimation of undegraded thyroglobulin in human serum. Endocrinology 81:42. 1967;
6. Torrigiani G, Doniach D, Roitt IM. Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease. J Clin Endocrinol Metab 29:305. 1969;
7. Schneider AB, Ikekubo K. Measurement of thyroglobulin in the circulation: clinical and technical considerations. Ann Lab Sci 9:230. 1979;
8. Bach JF, Carnaud C. Thymic factors. Prog Allergy 21:342. 1976;
9. Shenkman L, Bottone EJ. Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med 85:735. 1976;
10. Topliss D, How J, Lewis M, Row V, Volpe R. Evidence for cell-mediated immunity and specific suppressor T-lymphocyte dysfunction in Graves’ diseases and diabetes mellitus. J Clin Endocrinol Metab 57:700. 1983;
11. Tao TW, Gatenby PA, Leu SL, Pham H, Kriss JP. Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab 61:520. 1985;
12. Stenszky V, Kozma L, Balazs CS, Rochlitz SZ, Bear JC, Farid NR. The genetics of Graves’ disease: HLA and disease susceptibility. J Clin Endocrinol Metab 61:735. 1985;
13. Cho BY, Rhee BD, Lee DS, Lee MS, Kim GY, Lee HK, Koh CS, Min HK, Lee M. HLA and Graves’ disease in Korean. Seoul J Med 28:19. 1987;
14. Hanafusa T, Pujol-Borrel R, Chivato L, Russel RCG, Doniach D, Botazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity. Lancet 2:1111. 1983;
15. Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and T-lymphocyte phenotypes in Graves’ thyrotoxicosis, Hashimoto’s thyroiditis and nodular colloid goiter. Clin Exp Immunol 58:264. 1984;
16. Pujol-Borrell R, Hanafusa T, Chivato L, Bottazzo GF. Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature 304:71. 1983;
17. Bottazzo GF, Pujol-Borrel R, Hanafusa T. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115. 1983;
18. Faustman D, Hauptfield V, Davie JM, Lacy PE, Schreffler DC. Murine pancreatic beta cells express H-2K and H-D but not Ia antigens. J Exp Med 151:1563. 1980;
19. Kaufman JF, Auffray C, Korman AJ, Shackelford A, Strominger J. The class II molecules of the human and murine major histocompatibility complex. Cell 36:1. 1984;
20. Weir DM. Handbook of experimental immunology. 2Cellular Immunology 4th edth ed. p. 721. Oxford: Blackwell Scientific Publication; 1986.
21. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353. 1985;
22. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 2:1009. 1984;
23. Cha CY, Hwang ES, Cho MJ, Park MH, Ahn HS, Kim NK, Chang WH, Lee M. Production and characterization of lymphocytic hybridomas secreting monoclonal antibodies reactive with the cell surface antigens of acute lymphoblastic leukemia. J Korean Med Assoc 27:253. 1984;
24. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (AP-AAP complexes). J Histochem Cytochem 32:219. 1984;
25. Lansdorp PM, Kwast THVD, Boer MD, Zeijlemaker . Stepwise amplified immunoperoxidase (PAP) Staining:cellullar morphology in relation to membrane markers. J Histochem Cytochem 32:172. 1984;
26. Steinman RM. Dendritic cells. Transplantation 31:151. 1981;
27. Poulter LW. Antigen presenting cells in situ:their identification and involvement in immunopathology. Clin Exp Immunol 53:513. 1983;
28. Fuggle SV, Errasti P, Daar AS, Fabre JW, Ting A, Morris PJ. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Transplantation 35:385. 1983;
29. Rose NR, Friedman H, Fahey JL. Manual of clinical laboratory immunology 3rd edth ed. p. 924. Washington DC: American Society for Microbiology; 1986.
30. Weetman AP, Volkman DJ, Burman KD, Gerrard TL, Fauci AS. The in vitro regulation of human thyrocytes HLA-DR antigen expression. J Clin Endocrinol Metab 61:817. 1985;
31. Iwatani Y, Gersterin HC, Iitaka M, Row VV, Volpe R. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. J Clin Endocrinol Metab 63:695. 1986;
32. Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, Feldmann M. HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 329:304. 1987;
33. Londei M, Lamb JR, Bottazzo GF, Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639. 1984;
34. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 135:3750. 1985;
35. Fu SM, Chiorazzi N, Wang CY, Montazeri G, Kunkel HG, Ko HS, Gottlieb AB. Ia-bearing T-lymphocytes in man. J Exp Med 148:1423. 1978;
36. Reinherz EL, Morimoto C, Penta AC, Schlossman SF. Subpopulation of the T4 + inducer T-cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation. J Immunol 126:67. 1981;

Article information Continued

Fig. 1.

Closed arrow indicates positive rhodamine staining on the thyroid follicles of Graves’ disease patient. A large patch of cells adjacent to the thyroid follicles shows negative rhodamine staining (long arrow), but the central area of the patch shows positive rhodamine staining (open arrow).

Fig. 2.

The thyroid follicles of the normal control were DR-antigen negative (closed arrow). The yellow line along the inner side of an arteriole represents autofluorescence (open arrow) (See text.)

Fig. 3.

The thyrocytes of Graves’ disease patients were DR antigen-positive (short arrow), as is the large patch of cells adjacent to the thyroid follicles (long arrow).

Fig. 4.

The cells in the large patch were T1 antigen-positive except the central area.

Fig. 5.

Majority of the T1-positive cells were T4 antigen-positive.

Fig. 6.

Minority of the T1-positive cells were T8 antigen-positive.

Fig. 7.

Lymphocytes were also scattered in the thyroid follicles.

Table 1.

HLA-DR Expression on the Thyroid Follicles of Graves’ Disease Patients in Relation to the Laboratory Indices and Lymphocyte Infiltration

Sex/Age Duration of Disease (M) TBII (%) MCHA TGHA Lymphocyte Infiltration % Positivity of DR Ag
M/20 36 82 3202 1602 + + (−) 50
F/26 4 58 NC NC − ( + ) 80
F/39 60 75 3202 0 − (−) 20
F/30 6 15 802 0 − (−) 10
F/19 42 56 102 0 NC 0
F/32 60 48 0 0 + ( + ) 70
F/40 3 18 1602 0 − ( + ) 50
F/13 11 72 202 202 + ( + ) 50
F/20 25 37 402 0 NC 0
F/24 15 NC 802 402 NC 0
F/30 11 71 102 102 − (−) 80
*

MCHA: antimicrosomal hemagglutinin test

TGHA: antithyroglobulin hemagglutinin test

NC: not checked

*

The degree of lymphocyte infiltration means that of lymphoid follicles formed. The symbols in the parentheses denote the presence or absence of interstitial lymphocyte infiltration.